1.Rosenstein, NE et al. (1974) Meningococcal disease. New England Journal of Medicine 96, 1378–1388.
2.Devoe, IW (1982) The meningococcus and mechanisms of pathogenicity. Microbiology (Reading, England) 46, 162–190.
3.Broome, CV (1986) The carrier state: Neisseria meningitidis. Journal of Antimicrobial Chemotherapy 18(Suppl A), 25–34.
4.Harrison, LH et al. (2011) The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine 29, 3363–3371.
5.Tekin, RT et al. (2017) The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey. Human Vaccines & Immunotherapeutics 13, 1182–1189.
6.Harrison, OB et al. (2013) Description and nomenclature of Neisseria meningitidis capsule locus. Emerging Infectious Diseases 19, 566–573.
7.Moreno, J et al. (2015) Characterization of carriage isolates of Neisseria meningitidis in the adolescents and young adult population of Bogota (Colombia). PLoS ONE 10, e0135497.
8.Balmer, P et al. (2015) Impact of meningococcal vaccination on carriage and disease transmission: a review of the literature. Human Vaccines & Immunotherapeutics 14, 1118–1130.
9.Nunes, AM et al. (2016) Meningococcal carriage among adolescents after mass meningococcal C conjugate vaccination campaigns in Salvador, Brazil. PLoS ONE 11, e0166475.
10.Rodriguez, P et al. (2014) Meningococcal carriage prevalence in university students, 18–24 years of age in Santiago, Chile. Vaccine 32, 5677–5680.
11.Mac, LJ et al. (2006) Social behavior and meningococcal carriage in British teenagers. Emerging Infectious Diseases 12, 950–957.
12.Bruce, MG et al. (2001) Risk factors for meningococcal disease in college students. The Journal of American Medical Association 286, 688–693.
13.Kamiya, H et al. (2015) Unexpected high carriage rate of Neisseria meningitidis among dormitory residences in Tokyo, Japan. In Open Forum Infectious Diseases 2(suppl 1), 1163.
14.Soriano, GM et al. (2011) Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Expert Review of Anti-Infective Therapy 9, 761–774.
15.Trotter, CL et al. (2007) Meningococcal carriage in the African meningitis belt. The Lancet Infectious Diseases 18, 7797–7803.
16.Ali, O et al. (2015) (Menafricar Consortium) The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group A meningococcal conjugate vaccine. Journal of Infectious Diseases 212, 1298–1307.
17.Zhang, YT et al. (2019) Flora and molecular typing of Neisseria meningitidis in Suizhou City, Hubei Province, from 2010 to 2018. Chinese Vaccine and Immunization 2, 145–149.
18.Zhang, YW et al. (2016) Burden of Neisseria meningitidis infections in China: a systematic review and meta-analysis. Journal of Global Health 6, 020409.
19.Christensen, H et al. (2010) Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infection Diseases 10, 853–886.
20.Campbell, H et al. (2015) Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015. Eurosurveillance 20, 21188.
21.Ju, CY et al. (2008) Survey of prevalence of Neisseria meningitidis in heathy population in Shenzhen City in 2005 and 2006. China Tropical Medicine 8, 80–81.
22.Wang, YT et al. (2015) Analysis of Neisseria meningitidis carrier in healthy people in Hebei Province from 2006 to 2013. China Vaccine and Immunity 2, 31–35.
23.Niu, HC et al. (2018) Analysis of presence status, serotype distribution and antibiotic susceptibility of Neisseria meningitidis among healthy residents in Changping district of Beijing, 2016. Jiangsu Journal of Preventive 2, 131–134.
24.Yan, YF et al. (2018) Germ-carrying rate of epidemic cerebrospinal meningitis and molecular typing of bacteria among healthy population in Handan City, 2009–2015. Practical Preventive Medicine 25, 209–211.
25.Bennett, DE et al. (2004) PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. Journal of Clinical Microbiology 42, 1764–1765.
26.Zhu BQ, et al. (2012) Development of a multiplex PCR assay for detection and genogrouping of Neisseria meningitidis. Journal of Clinical Microbiology 50, 46–51.
27.Jennifer, MDL et al. (2003) Genetic basis for nongroupable Neisseria meningitidis. Journal of Infectious Diseases 187, 1616–1628.
28.Bai, X et al. (2019) Prevention and control of meningococcal disease: updates from the Global Meningococcal Initiative in Eastern Europe. Journal of Infection 79, 528–541.
29.Dretler, AW et al. (2018) Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Human Vaccines & Immunotherapeutics 14, 1146–1160.
30.Borrow, R et al. (2013) Effectiveness of meningococcal serogroup C vaccine program. Vaccine 31, 4477–4486.
31.Vetter, V et al. (2016) Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. Expert Review of Vaccines 15, 641–658.
32.Stuart, JM et al. (1987) An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey. Epidemiology and Infection 99, 579–589.
33.Orren, A et al. (1994) Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa. Journal of Clinical Microbiology 32, 2185–2191.
34.Gilmore, A et al. (1999) Meningococcal disease at the University of Southampton: outbreak investigation. Epidemiology and Infection 123, 185–192.
35.Neal, KR et al. (2000) Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. British Medical Journal 320, 846–849.